AWM
MRK icon

Aberdeen Wealth Management’s Merck MRK Stock Holding History

Aberdeen Wealth Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$193K Sell
1,500
-310
-17% -$36.3K 0.09% 126
2026
Q1 		$218K Buy
+1,810
New +$209K 0.1% 148
2024
Q4 		– Sell
-1,853
Closed -$210K – 168
2024
Q3 		$210K Sell
1,853
-2,265
-55% -$269K 0.14% 144
2024
Q2 		$510K Sell
4,118
-87
-2% -$11.2K 0.34% 84
2024
Q1 		$555K Buy
4,205
+2,273
+118% +$280K 0.32% 82
2023
Q4 		$211K Sell
1,932
-2,263
-54% -$235K 0.15% 140
2023
Q3 		$432K Buy
4,195
+4
+0.1% +$431 0.33% 86
2023
Q2 		$484K Buy
4,191
+4
+0.1% +$454 0.35% 79
2023
Q1 		$445K Buy
4,187
+5
+0.1% +$540 0.33% 85
2022
Q4 		$464K Buy
4,182
+5
+0.1% +$511 0.35% 79
2022
Q3 		$360K Buy
4,177
+4
+0.1% +$357 0.32% 90
2022
Q2 		$380K Buy
4,173
+5
+0.1% +$443 0.3% 90
2022
Q1 		$342K Buy
4,168
+6
+0.1% +$473 0.23% 113
2021
Q4 		$319K Sell
4,162
-195
-4% -$15.5K 0.21% 116
2021
Q3 		$327K Buy
4,357
+5
+0.1% +$380 0.32% 102
2021
Q2 		$338K Buy
4,352
+7
+0.2% +$521 0.31% 103
2021
Q1 		$320K Sell
4,345
-466
-10% -$34.4K 0.25% 110
2020
Q4 		$376K Buy
4,811
+476
+11% +$36.4K 0.28% 96
2020
Q3 		$343K Sell
4,335
-1,394
-24% -$109K 0.33% 90
2020
Q2 		$423K Buy
5,729
+1,404
+32% +$106K 0.45% 74
2020
Q1 		$318K Buy
4,325
+4
+0.1% +$314 0.39% 80
2019
Q4 		$375K Buy
+4,321
New +$355K 0.28% 95

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Aberdeen Wealth Management's MRK Position: Q2 2026 in Review

Aberdeen Wealth Management reduced its Merck (MRK) stake by 17% in Q2 2026, selling an estimated $36.3K and leaving 1,500 shares worth $193K. The position accounts for 0.09% of the portfolio, ranked #126.

Aberdeen Wealth Management first reported a position in MRK in Q4 2019 and has held it in 22 quarters since. The position peaked at $555K in Q1 2024. 3,818 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Aberdeen Wealth Management held 1,500 shares of Merck worth $193K as of Q2 2026.
  • Aberdeen Wealth Management sold 310 Merck shares in Q2 2026, an estimated $36.3K.
  • Merck made up 0.09% of Aberdeen Wealth Management's portfolio in Q2 2026, its #126 holding.
  • Aberdeen Wealth Management first reported a position in Merck in Q4 2019 and has held it in 22 quarters since.
  • Aberdeen Wealth Management's Merck position peaked at $555K in Q1 2024.
  • 3,818 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Aberdeen Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.